查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1266135

局部給藥的全球市場

Topical Drug Delivery
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 94 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

局部給藥的全球市場在2030年前將達到1,768億美元

在COVID-19後改變的商務環境中，2022年1,142億美元的局部給藥的全球市場，在2030年前將達到1,768億美元的規模，在2022年～2030年預計將以年複合成長率5.6 %增長。本報告所分析之市場區隔之一的半固態製劑年複合成長率將記錄5.7％，到分析期間結束時將達到696億美元。考慮疫情後的復甦，液體製劑領域今後8年的年複合成長率將修正為5％。

美國市場估算為334億美元，中國則將以年複合成長率5.1％成長預測

美國的局部給藥市場，2022年334億美元。作為世界第2大經濟大國的中國，在2022年～2030年年複合成長率預計將為5.1％，在2030年前將達到308億美元的市場規模。其他熱門的地區市場有日本和加拿大，在2022年～2030年預計將各以5.3％和4％的速度成長。在歐洲市場中，德國以年複合成長率4.3％成長。

調查對像企業範例

  • 3M
  • Acrux Limited
  • Bayer AG
  • Biofarmitalia s.r.l
  • Cipla Inc.
  • Crescita Therapeutics Inc.
  • Galderma S.A.
  • GlaxoSmithKline plc
  • Janssen Global Services, LLC
  • Lohmann Therapie-Systeme AG
  • Medpharm
  • Mylan N.V.
  • Nitto Denko Corporation
  • Novartis AG
  • Pharmatek Laboratories, Inc.
  • Pocono Coated Products LLC
  • Skinvisible Pharmaceuticals, Inc.
  • Stiefel Laboratories, Inc.
  • Tapemark
  • Valeant Pharmaceuticals International, Inc.
  • West Pharmaceutical Services, Inc.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP22960

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Topical Drug Delivery Market to Reach $176.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Topical Drug Delivery estimated at US$114.2 Billion in the year 2022, is projected to reach a revised size of US$176.8 Billion by 2030, growing at aCAGR of 5.6% over the period 2022-2030. Semi-Solid Formulations, one of the segments analyzed in the report, is projected to record 5.7% CAGR and reach US$69.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Liquid Formulations segment is readjusted to a revised 5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $33.4 Billion, While China is Forecast to Grow at 5.1% CAGR

The Topical Drug Delivery market in the U.S. is estimated at US$33.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$30.8 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Select Competitors (Total 43 Featured) -

  • 3M
  • Acrux Limited
  • Bayer AG
  • Biofarmitalia s.r.l
  • Cipla Inc.
  • Crescita Therapeutics Inc.
  • Galderma S.A.
  • GlaxoSmithKline plc
  • Janssen Global Services, LLC
  • Lohmann Therapie-Systeme AG
  • Medpharm
  • Mylan N.V.
  • Nitto Denko Corporation
  • Novartis AG
  • Pharmatek Laboratories, Inc.
  • Pocono Coated Products LLC
  • Skinvisible Pharmaceuticals, Inc.
  • Stiefel Laboratories, Inc.
  • Tapemark
  • Valeant Pharmaceuticals International, Inc.
  • West Pharmaceutical Services, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Topical Drug Delivery - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Topical Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Topical Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Topical Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Semi-Solid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Semi-Solid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Semi-Solid Formulations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Liquid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Liquid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Liquid Formulations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Solid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Solid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Solid Formulations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Transdermal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Transdermal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Transdermal Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Burn Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Burn Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Burn Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Dermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Dermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Dermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Nasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Nasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Nasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Ophthalmic Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Ophthalmic Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Ophthalmic Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Rectal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Rectal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 39: World 16-Year Perspective for Rectal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Vaginal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Vaginal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 42: World 16-Year Perspective for Vaginal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 43: World Topical Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • JAPAN
    • Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • CHINA
    • Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: China 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • EUROPE
    • Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Topical Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Topical Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • FRANCE
    • Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: France 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • GERMANY
    • Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2014, 2023 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2014, 2023 & 2030

IV. COMPETITION